Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Realty drags Indian stock markets
Thu, 23 Jun 09:30 am

Asian stock markets have opened the day on a mixed note. Stock markets in South Korea (up 0.1%) and China (up 0.2%) are trading in the green while Indonesia (down 0.4%), Hong Kong (down 0.7%), and Japan (down 0.3%) are trading in the red. The Indian stock markets have opened the day on a weak note. Stocks in the realty and healthcare space are leading the losses.

The BSE-Sensex is trading down by 23 points (0.3%) and the NSE-Nifty is down by around 10 points (0.2%). Midcap and small cap stocks are trading in the red as well, with the BSE Midcap and BSE Small cap indices down by 0.3% and 0.1% respectively. The rupee is trading at 44.78 to the US dollar.

Pharma stocks have opened the day on a weak note with Glenmark and Biocon trading in the red. Dr Reddy's Laboratories (DRL) launched Levofloxacin tablets which is an antibiotic used for treating bacterial infections. The product has been launched in the US market. This drug is the generic version of Levaquin tablets. In 2011, the Levaquin brand had US sales of about US $1 bn. The tablets are available in 250 mg, 500 mg and 750 mg dosages in the bottles form. The patent for this product expired in June 2011. Many other Indian companies have received approvals to market the same drug. The stock is however currently trading in the negative zone.

Steel stocks have opened the day on a weak note with Ispat Industries, JSW Steel and Tata Steel leading the losses. Steel major, Tata Steel has joined hands with JSW, Jindal Steel, SAIL, NMDC and Rashtriya Ispat Nigam to form a consortium. The consortium would jointly bid for the Hajigak iron ore deposits in Afghanistan. These deposits are considered to be the second largest deposit of the ore in the world. As per the agreement, the PSU majors would hold about 60% of the total share in the consortium. The 3 private players would be equally sharing the remainder share. The mines are estimated to contain 1.8 m tones of iron ore. The mines that have been broken down into four blocks will be opened for bidding on 3rd August, 2011.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Realty drags Indian stock markets". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.